PubMed:12587019 / 12550-12787 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T88","span":{"begin":0,"end":237},"obj":"DRI_Background"}],"text":"CONCLUSIONS: Under the conditions of these 2-year gavage studies, there was some evidence of carcinogenic activity of salicylazosulfapyridine in male and female F344/N rats based on increased incidences of neoplasms in the urinary tract."}